Published in Obesity and Diabetes Week, July 20th, 2009
At 28 weeks, evaluable patients with a starting body mass index (BMI) less than 35 kg/m2 (n=3D149), and treated with the highest pramlintide/metreleptin doses, experienced significantly more weight loss on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week